Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study.

Address: Faculty of Medicine, University of Southampton, Southampton, UK.; Wessex Regional Genetics Laboratory, Salisbury NHS Foundation Trust, Salisbury, UK.; Department of Emergency and Organ Transplantation (D.E.T.O.)-Hematology and Stem Cell Transplantation Unit, University of Bari "Aldo Moro", Bari, Italy.; Department of Pathology, Zealand University Hospital, Roskilde, Denmark.; Department of Medical Oncology and Hematology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Laboratory of Medical Genetics National Specialized Hospital for Active Treatment of Hematological Diseases, Sofia, Bulgaria.; Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.; Laboratory of Hematology, University Hospital Saint-Louis, Université de Paris, Paris, France.; Department of Genetics and Research Centre, Portuguese Oncology Institute of Porto, Porto, Portugal.; Department of Molecular Hemato-Oncology, LHUB-ULB, Brussels, Belgium.; Pathology Department, Hospital Clinic, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERONC, Barcelona, Spain.; Fundeni Clinical Institute, Hematology Department, Bucharest, Romania.; Hematology Department, Faculty of Medicine, University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.; Laboratório de Hemato-Oncologia-LHO Instituto Português de Oncologia Francisco Gentil, Lisbon, Portugal.; Institute for Hematology and Oncology (IHO GmbH), Mannheim, Germany.; University Hospital of Bordeaux, Laboratory of Hematology, Haut Lévêque Hospital, Pessac, France.; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.; University of Leipzig Medical Center, Department for Hematology, Cellular Therapies and Hemostaseology, Leipzig, Germany.; Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.; Poznan University of Medical Sciences, Department of Hematology and Bone Marrow Transplantation, Poznan, Poland.; Hematology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Las Palmas, Spain.; Laboratory of Chemical and Clinical Analysis "Area 3" A.O.U San Luigi Gonzaga-Orbassano, Turin, Italy.; SIHMDS Hosted by Imperial College Healthcare NHS Trust at Hammersmith Hospital, London, UK.; Hospices Civils de Lyon, Hôpital Lyon Sud, Service d'Hématologie Biologique, Pierre-Bénite, France.; Section of Molecular Diagnostics, Clinical Genetics, Region Skåne, Lund, Sweden.; Ritus Biotec Laboratory, Codlea-Brasov, Romania.; Transilvania University, Brasov, Romania.; Department of Molecular Medicine and Medical Biotechnology University 'Federico II' and CEINGE-Advanced Biotechnologies, Naples, Italy.; Hematology Department, Hospital Regional Universitario de Málaga, IBIMA, Málaga, Spain.; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Department of Genomics, Turku University Hospital Laboratories, Turku, Finland.; Cancer Molecular Diagnostics, St. James's Hospital, Dublin, Ireland.; Labdia Labordiagnostik/St. Anna Children´s Cancer Research Institute (CCRI), Vienna, Austria.; Laboratory of Molecular Genetics, Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases, Budapest, Hungary.; Pathology Department, University Clinical Center Tuzla, Policlinic for Laboratory Diagnostics, Tuzla, Bosnia and Herzegovina.; Department of Medical Genetics, National Cancer Institute, Bratislava, Slovakia.; Medical University of Vienna, Department of Laboratory Medicine, Vienna, Austria.; MLL Munich Leukemia Laboratory, Munich, Germany.; III. Medizinische Klinik, Universitätsmedizin Mannheim, Mannheim, Germany.; CHU Lille, Laboratoire d'hématologie, F-59000, Lille, France.; University Hospital Bern, Bern, Switzerland.; University of Bern, Bern, Switzerland.; Haematology Research Laboratory, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.; Department of Haematology, University Medical Centre Ljubljana, Ljubljana, Slovenia.; Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.; Second Medical Department, University Hospital Schleswig-Holstein, Campus Kiel, Germany.; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, 28041, Madrid, Spain.; Hematological Malignancies Clinical Research Unit, CNIO, 28029, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, 28029, Madrid, Spain.; West Midlands Regional Genetics Laboratory, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.; Abteilung Hämatologie/Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany.; Molecular Diagnostics Laboratory, Hematology Department and HCT Unit, George Papanicolaou General Hospital, Thessaloniki, Greece.; HemoDiagnostic Laboratory, Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.; Amsterdam University Medical Center, Amsterdam, The Netherlands.; IRCSS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia "Seràgnoli", Bologna, Italy.; Department of Clinical and Experimental Medicine, Center of Experimental Oncology and Hematology, University of Catania, Catania, Italy.; Molecular Hemapathology, Oslo University Hospital, Oslo, Norway.; Haematological Malignancy Diagnostic Service, Leeds Teaching Hospitals, Leeds, UK.; University Hospital Center Zagreb, Zagreb, Croatia.; The University Hospital in Krakow, Krakow, Poland.; Institute of Hematology and Blood Transfusion, Prague, Czech Republic.; Faculty of Medicine, University of Southampton, Southampton, UK. [email protected].; Wessex Regional Genetics Laboratory, Salisbury NHS Foundation Trust, Salisbury, UK. [email protected].